Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Viruses
|
May 28, 2022
An Inspiring Journey of Hope and Persistence: Life Lessons with Françoise Barré-Sinoussi
Kiho Tanaka, Paula M Cevaal, Rachel D Pascoe
Tuberculosis (Edinburgh, Scotland)
|
September 28, 2019
TB-IRIS pathogenesis and new strategies for intervention: Insights from related inflammatory disorders
Paula M Cevaal, Linda-Gail Bekker, Sabine Hermans
Mathematical Biosciences
|
November 5, 2022
On predicting heterogeneity in nanoparticle dosage
Celia V Dowling, Paula M Cevaal, Matthew Faria, et al.
Journal of Visualized Experiments : Jove
|
October 25, 2022
Experimental Quantification of Interactions Between Drug Delivery Systems and Cells In Vitro: A Guide for Preclinical Nanomedicine Evaluation
Paula M Cevaal, Michael Roche, Sharon R Lewin, et al.
Current Opinion in HIV and AIDS
|
July 19, 2025
CRISPR/Cas9 for achieving postintervention HIV control
Michael A Moso, Michael Roche, Paula M Cevaal, et al.
Frontiers in Immunology
|
April 28, 2025
HIV Tat as a latency reversing agent: turning the tables on viral persistence
Bridget M Fisher, Paula M Cevaal, Michael Roche, et al.
ACS Applied Bio Materials
|
January 11, 2022
Acoustofection: High-Frequency Vibrational Membrane Permeabilization for Intracellular siRNA Delivery into Nonadherent Cells
Shwathy Ramesan, Amgad R Rezk, Paula M Cevaal, et al.
ACS Nano
|
February 18, 2021
<i>In Vivo</i> T Cell-Targeting Nanoparticle Drug Delivery Systems: Considerations for Rational Design
Paula M Cevaal, Abdalla Ali, Ewa Czuba-Wojnilowicz, et al.
Nature Communications
|
July 1, 2026
Targeting rapidly cycling receptors CD2 and CD7 increases nanoparticle delivery to primary CD4<sup>+</sup> T cells
Paula M Cevaal, Abdalla Ali, Marcel Doerflinger, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Viruses
|
May 28, 2022
An Inspiring Journey of Hope and Persistence: Life Lessons with Françoise Barré-Sinoussi
Kiho Tanaka, Paula M Cevaal, Rachel D Pascoe
Tuberculosis (Edinburgh, Scotland)
|
September 28, 2019
TB-IRIS pathogenesis and new strategies for intervention: Insights from related inflammatory disorders
Paula M Cevaal, Linda-Gail Bekker, Sabine Hermans
Mathematical Biosciences
|
November 5, 2022
On predicting heterogeneity in nanoparticle dosage
Celia V Dowling, Paula M Cevaal, Matthew Faria, et al.
Journal of Visualized Experiments : Jove
|
October 25, 2022
Experimental Quantification of Interactions Between Drug Delivery Systems and Cells In Vitro: A Guide for Preclinical Nanomedicine Evaluation
Paula M Cevaal, Michael Roche, Sharon R Lewin, et al.
Current Opinion in HIV and AIDS
|
July 19, 2025
CRISPR/Cas9 for achieving postintervention HIV control
Michael A Moso, Michael Roche, Paula M Cevaal, et al.
Frontiers in Immunology
|
April 28, 2025
HIV Tat as a latency reversing agent: turning the tables on viral persistence
Bridget M Fisher, Paula M Cevaal, Michael Roche, et al.
ACS Applied Bio Materials
|
January 11, 2022
Acoustofection: High-Frequency Vibrational Membrane Permeabilization for Intracellular siRNA Delivery into Nonadherent Cells
Shwathy Ramesan, Amgad R Rezk, Paula M Cevaal, et al.
ACS Nano
|
February 18, 2021
<i>In Vivo</i> T Cell-Targeting Nanoparticle Drug Delivery Systems: Considerations for Rational Design
Paula M Cevaal, Abdalla Ali, Ewa Czuba-Wojnilowicz, et al.
Nature Communications
|
July 1, 2026
Targeting rapidly cycling receptors CD2 and CD7 increases nanoparticle delivery to primary CD4<sup>+</sup> T cells
Paula M Cevaal, Abdalla Ali, Marcel Doerflinger, et al.
Page
of 1